Patents

Description

COMPOZIŢIE FARMACEUTICĂ PENTRU TRATAMENTUL UNOR AFECŢIUNI PSIHOTICE ŞI UTILIZAREA ACESTEIA

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO119224

Date: 30.06.2004

Inventor(s):

MESENS LEAN LOUIS [BE]

RICKEY MICHAEL E [US]

ATKINS THOMAS J [US]

Applicant(s):
JANSSEN PHARMACEUTICA NV [BE]
MEDISORB TECHNOLOGIES INTERNAT [US]
Classification:
International patent classification (IPC):
A61K31/505; A61K31/517; A61K31/519; A61K47/30; A61K47/32; A61K9/16; A61K9/26; A61K9/50; A61K9/52; A61P25/00
Cooperative patent classification (CPC):
A61K31/505 (EP, US); A61K31/517 (EP, US); A61K31/519 (EP, US); A61K9/0024 (EP, US); A61K9/1647 (EP, US); A61P25/00 (EP); A61P25/18 (EP); A61P43/00 (EP)
Application info:
No.: RO19960001013
Date: 11.11.1994
Priority number(s):
US19930154403 19.11.1993 ; WO1994EP03754 11.11.1994
Related patents:
ATE288270; AU694147; AU8142594; BG100632; BG63246; CL2004001182; CN1074923; CN1137756; CZ137396; CZ293764; DE69434258; DK0729357; EP0729357; ES2236700; FI117122; FI962111; HK1010694; HU219487; HUT73501; IL111647; JP3645906; JPH09505286; KR100354270; MX9408969; MY113298; NO309226; NO962040; NZ276088; PL314481; PT729357; RU2178695; SG47445; SI0729357; SK282231; SK64096; US2002098233; US2003165571; US2005025828; US2006182810; US2008063721; US2008069885; US5688801; US5770231; US5965168; US6110921; US6368632; US6544559; US6803055; US7118763; US7547452; WO9513814; ZA949191
Description:

Invenţia se referă la o compoziţie care conţine un purtător acceptabil farmaceutic şi microparticule biodegradabile şi biocompatibile care conţin 1...90% 1,2-benzazol cu formula: Invenţia se referă şi la utilizarea 1,2 - benzizoxazoli şi 1,2-benzizotiazoli 3-piperidinil substituiţi, pentru prepararea unui medicament necesar tratamentului afecţiunilor psihotice. ŕ

Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email